ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

EBS Emergent Biosolutions Inc

3.86
0.56 (16.97%)
After Hours
Last Updated: 06:08:14
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Emergent Biosolutions Inc EBS NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.56 16.97% 3.86 06:08:14
Open Price Low Price High Price Close Price Previous Close
3.45 3.36 4.02 3.89 3.30
more quote information »

Recent News

Date Time Source Heading
02/5/202406:57GLOBEEmergent BioSolutions Reports First Quarter 2024 Financial..
02/5/202406:10GLOBEEmergent BioSolutions Announces Strategic Operational..
02/5/202401:03GLOBEEmergent BioSolutions Releases New Survey Findings..
01/5/202407:26GLOBEEmergent BioSolutions Announces Amendment to its Existing..
22/4/202422:05GLOBEEmergent BioSolutions to Release First Quarter 2024..
01/4/202423:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
28/3/202423:15GLOBEEmergent BioSolutions Continues to Broaden Access, Awareness..
25/3/202423:05GLOBEEmergent BioSolutions Receives NAI Status for Baltimore..
09/3/202408:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202412:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:31GLOBEEmergent BioSolutions Reports Fourth Quarter 2023 Financial..
07/3/202408:15EDGAR2Form 8-K - Current report
06/3/202422:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
05/3/202410:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202410:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202410:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:00GLOBEEmergent BioSolutions to Release Fourth Quarter & Full Year..
28/2/202412:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202412:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202423:25EDGAR2Form 8-K - Current report
21/2/202423:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
11/1/202423:41EDGAR2Form 8-K - Current report
10/1/202400:40EDGAR2Form 8-K - Current report
09/1/202423:30GLOBEEmergent BioSolutions to Present at the 42nd Annual J.P...
27/12/202322:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
12/12/202309:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/12/202323:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202323:15EDGAR2Form 8-K - Current report
28/11/202322:59GLOBEEmergent BioSolutions Receives $75 Million Contract Option..
24/11/202323:30GLOBEEmergent BioSolutions Receives NYSE Notice Regarding Delayed..
24/11/202323:17EDGAR2Form 8-K - Current report
17/11/202308:11EDGAR2Form 8-K - Current report
15/11/202311:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202311:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202311:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202308:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/11/202309:38GLOBEEmergent BioSolutions Reports Third Quarter 2023 Financial..
09/11/202308:21EDGAR2Form 8-K - Current report
31/10/202307:45GLOBEUPDATE: Emergent BioSolutions to Release Third Quarter 2023..
19/10/202321:30GLOBEEmergent BioSolutions to Release Third Quarter 2023..
16/10/202322:00PRNUSEmergent BioSolutions Partners with Emmitt Smith to Launch..
06/10/202310:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202310:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202310:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/10/202310:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/10/202322:42EDGAR2Form 8-K - Current report
02/10/202322:49EDGAR2Form 8-K - Current report
02/10/202322:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
30/8/202320:30EDGAR2Form 8-K - Current report
30/8/202319:59GLOBEEmergent BioSolutions’ NARCAN® Nasal Spray Launches Over the..

Your Recent History

Delayed Upgrade Clock